Infectivity-enhancing antibodies to Ebola virus glycoprotein.
about
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1Antibody-dependent enhancement of Ebola virus infectionReplicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutationAntigenic subversion: a novel mechanism of host immune evasion by Ebola virusInfection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement LevelsInteraction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.Characterization of the envelope glycoprotein of a novel filovirus, lloviu virusEnhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophagesEbola virus VP40 drives the formation of virus-like filamentous particles along with GPHuman Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in miceFunctional mapping of the nucleoprotein of Ebola virus.Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.Passive antibody administration (immediate immunity) as a specific defense against biological weapons.In silico analysis suggests interaction between Ebola virus and the extracellular matrixAntibody-dependent enhancement of Marburg virus infectionSingle immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.Monoclonal antibodies and toxins--a perspective on function and isotype.Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus InfectionReplication-deficient ebolavirus as a vaccine candidate.Fc receptors in antibody-dependent enhancement of viral infections.Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus.Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.Quantification of Filovirus Glycoprotein-Specific Antibodies.Filovirus tropism: cellular molecules for viral entry.Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged.Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species.
P2860
Q24329246-4DCE9AAB-A057-4E1E-95D1-3CF4B28DAB1EQ24683154-600AA5FB-FB9E-403C-80DC-9DB2F1DAB9CBQ24798257-9C55D3E7-E0D4-4B33-A378-F4F999E85DD0Q27339643-13FDC282-C7AD-41EA-B15B-F97A3C1CDF3BQ27485321-B209EC35-588D-4475-9656-7DCB60510B14Q30386606-08B6BAD9-4570-4D15-AE7C-90521BB5EB3DQ30391355-4DC58E5A-C421-4FD4-BA5F-FC4FE9C192C8Q30449524-2FDCAF82-CBA7-431A-83AC-F451DAEDB6ECQ34338585-80F3A012-4866-4C60-8AE3-E71E43B895B8Q34463780-7098579D-582E-4705-A49F-CA219A8421CDQ34464533-472AFDEC-9CA4-4726-B655-9FFC98DD285CQ34509643-B2D0A099-38E6-43B0-A041-EF6A7195F3F2Q34545840-9FAA2B3F-F3C8-42D6-8D00-AAA8E1A18CE7Q34579231-74847349-BD04-47BF-8B82-FF6957359C52Q34762095-F0ACA030-294B-4423-9FFE-AE6CB4AB1806Q35099536-533BBF0C-2E9E-4137-B985-6E7C4D522F79Q35299989-D4C6949E-DD9B-4A67-840A-19367B53C044Q35300062-5921F252-6F19-4E5D-8119-9035079826F7Q35955731-787BAE47-D8BF-430D-A057-C0E46ECB1893Q36099489-95F603AB-EBBA-49A8-BFD1-F90E7B3D9FF1Q36236428-FFFEBFE2-B2BB-4676-9DA7-579A1922DA2EQ37145203-C7315DA5-FB31-400B-8FDA-262174E3654DQ38615396-DAFDD832-E3B6-4BAE-9A6C-90FD9BED6043Q38785688-C6B2A7F4-7725-4198-95C7-437D8E9D052DQ39245066-7A065FF1-D057-4D6C-9D5E-A018BB314E55Q39540578-153A4372-F09D-4B70-B804-64E5028F7135Q40054387-EB123E19-E9B8-43F2-97E2-B5D6CD1595E3Q40295070-00A0B7F2-8BA3-46B5-8CB4-273285DE769DQ42428474-701E8868-272A-409C-A13C-F06DB0F493EBQ47558244-8BF0612E-70AC-45B4-BC10-4C85970BFE28
P2860
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@ast
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@en
type
label
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@ast
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@en
prefLabel
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@ast
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@en
P2093
P2860
P1433
P1476
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.5.2324-2330.2001
P50
P577
2001-03-01T00:00:00Z